Supplementary Table 3.

Predictors of EUS-radiofrequency ablation and ethanol ablation of pancreatic neuroendocrine tumors

Factor	Technical success	Clinical success	Adverse events	Pancreatitis
EUS-RFA
Age	−0.003, P=0.94	0.009, P=0.86	0.0004, P=0.99	−0.01, P=0.80
Functioning	0.063, P=0.55	0.008, P=0.88	−0.071, P=0.35	−0.001, P=0.98
Size	−0.02, P=0.77	−0.02, P=0.78	−0.09, P=0.2149	−0.001, P=0.98
Head/neck	0.076, P=0.52	0.24, P=0.032	−0.08, P=0.51	0.03, P=0.65
Body/tail	0.086, P=0.38	0.04, P=0.53	−0.054, P=0.46	0.006, P=0.92
Ethanol ablation
Age	−0.065, P=0.44	−0.04, P=0.59	0.03, P=0.77	−0.001, P=0.98
Functioning	0.03, P=0.77	0.09, P=0.36	−0.08, P=0.56	−0.04, P=0.66
Size	−0.001, P=0.99	−0.10, P=0.78	−0.22, P=0.66	−0.04, P=0.9
Head/neck	0.09, P=0.24	0.11, P=0.15	−0.08, P=0.32	−0.06, P=0.17
Body/tail	0.13, P=0.20	0.14, P=0.16	−0.14, P=0.14	−0.09, P=0.14
Ethanol amount	−0.59, P=0.38	−0.39, P=0.52	1.23, P=0.09	0.85, P=0.16

Values are regression coefficient with P value, Bold indicated significant P value. RFA: Radiofrequency ablation